Short-term glucocorticoids for flares in people with rheumatoid arthritis receiving disease-modifying anti-rheumatic drugs (DMARDs)

This is a protocol for a Cochrane Review (intervention). The objectives are as follows:

The primary objective is to assess the benefits and harms of short-term glucocorticoid therapy (six months or less) compared to placebo, for adults with rheumatoid arthritis who experience a disease flare while receiving standard disease-modifying anti-rheumatic drug (DMARD) therapy.

The secondary objective is to maintain the currency of the evidence, using a living systematic review approach.

This is a protocol.